跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXALIPLATIN INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OXALIPLATIN INJECTION, USP
Authorized
STANDARD
OXALIPLATIN INJECTION, USP
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8e6dc7f2c8958550
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
8e6dc7f2c8958550
Drug Approval Canada Name
OXALIPLATIN INJECTION, USP
Product Name
OXALIPLATIN INJECTION, USP
Status
Marketed
Status Date
2022-03-31
Original Market Date
2022-03-31
Din
02457423
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XA03 OXALIPLATIN
Atc Name
l 01 xa 03
Aig Number
0152220003
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
OXALIPLATIN
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8e6dc7f2c8958550
Type
Standard
Back to Health Canada Approvals